Page last updated: 2024-11-05

delavirdine and HIV

delavirdine has been researched along with HIV in 11 studies

Delavirdine: A potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1.
delavirdine : The amide resulting from the formal condensation of 5-[(methylsulfonyl)amino]-1H-indole-2-carboxylic acid and 4-amino group of 1-[3-(isopropylamino)pyridin-2-yl]piperazine, delavirdine is a non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1. Viral resistance emerges rapidly when delavirdine is used alone, so it is therefore used (as the methanesulfonic acid salt) with other antiretrovirals for combination therapy of HIV infection.

HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.

Research Excerpts

ExcerptRelevanceReference
"Saquinavir was common in all study arms, and the study investigated relationships among characteristics of patients, saquinavir area under the curve (AUC) and trough concentrations (C(min)), and virologic response."2.71Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359. ( Acosta, EP; Brundage, RC; Fletcher, CV; Gulick, RM; Haubrich, R; Jiang, H; Katzenstein, D, 2004)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (27.27)18.2507
2000's5 (45.45)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, Z1
Vince, R1
Tian, Y1
Du, D1
Rai, D1
Wang, L1
Liu, H1
Zhan, P1
De Clercq, E1
Pannecouque, C1
Liu, X1
Gu, SX1
Xue, P1
Ju, XL1
Zhu, YY1
Kuo, YC1
Lee, CL1
Gulick, RM2
Hu, XJ1
Fiscus, SA1
Fletcher, CV2
Haubrich, R2
Cheng, H1
Acosta, E1
Lagakos, SW1
Swanstrom, R1
Freimuth, W1
Snyder, S1
Mills, C1
Fischl, M1
Pettinelli, C1
Katzenstein, D2
Jiang, H1
Brundage, RC1
Acosta, EP1
Gianotti, N1
Boeri, E1
Maillard, M1
Serra, G1
Ratti, D1
Gallotta, G1
Vacchini, D1
Tremolada, Y1
Castagna, A1
Miller, V1
Staszewski, S1
Boucher, CA1
Phair, JP1
James, JS1
Bowers, M1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Activity of the Soft Gelatin Capsule of Saquinavir (SQVsgc) in Combination With Ritonavir or Nelfinavir and Combinations of Delavirdine and/or Adefovir Dipivoxil in HIV-Infected Subjects With Prior Indinavir Use and Viral Loads From 2,000 to 200,000 Copie[NCT00000892]300 participants InterventionalCompleted
CID 0708 - Sex, Aging and Antiretroviral Pharmacokinetics[NCT00666055]11 participants (Actual)Observational2008-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for delavirdine and HIV

ArticleYear
Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase.
    Bioorganic & medicinal chemistry, 2016, 11-01, Volume: 24, Issue:21

    Topics: Anti-HIV Agents; Drug Design; HIV; HIV Infections; HIV Integrase Inhibitors; HIV Reverse Transcripta

2016
Clinical experience with non-nucleoside reverse transcriptase inhibitors.
    AIDS (London, England), 1997, Volume: 11 Suppl A

    Topics: Acetamides; Acetophenones; Animals; Anti-HIV Agents; Delavirdine; HIV; HIV Infections; Nevirapine; N

1997

Trials

2 trials available for delavirdine and HIV

ArticleYear
Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359.
    The Journal of infectious diseases, 2002, Sep-01, Volume: 186, Issue:5

    Topics: Antiviral Agents; CD4 Lymphocyte Count; Delavirdine; Double-Blind Method; Drug Therapy, Combination;

2002
Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359.
    The Journal of infectious diseases, 2004, Apr-01, Volume: 189, Issue:7

    Topics: Adenine; Adult; Anti-HIV Agents; Delavirdine; Double-Blind Method; Drug Therapy, Combination; Female

2004
Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359.
    The Journal of infectious diseases, 2004, Apr-01, Volume: 189, Issue:7

    Topics: Adenine; Adult; Anti-HIV Agents; Delavirdine; Double-Blind Method; Drug Therapy, Combination; Female

2004
Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359.
    The Journal of infectious diseases, 2004, Apr-01, Volume: 189, Issue:7

    Topics: Adenine; Adult; Anti-HIV Agents; Delavirdine; Double-Blind Method; Drug Therapy, Combination; Female

2004
Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359.
    The Journal of infectious diseases, 2004, Apr-01, Volume: 189, Issue:7

    Topics: Adenine; Adult; Anti-HIV Agents; Delavirdine; Double-Blind Method; Drug Therapy, Combination; Female

2004

Other Studies

7 other studies available for delavirdine and HIV

ArticleYear
Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: introducing a diketoacid functionality into delavirdine.
    Bioorganic & medicinal chemistry, 2008, Apr-01, Volume: 16, Issue:7

    Topics: Delavirdine; Drug Design; HIV; HIV Integrase; HIV Integrase Inhibitors; HIV Reverse Transcriptase; K

2008
Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives.
    Bioorganic & medicinal chemistry, 2014, Apr-01, Volume: 22, Issue:7

    Topics: Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Design; Heterocyclic Compounds; HIV; HIV Rev

2014
Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier.
    Colloids and surfaces. B, Biointerfaces, 2012, Feb-01, Volume: 90

    Topics: Ammonium Sulfate; Anti-HIV Agents; Astrocytes; Biological Transport; Blood-Brain Barrier; Bradykinin

2012
In vivo dynamics of the 103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in HIV-infected patients: preliminary results.
    The new microbiologica, 2004, Volume: 27, Issue:2 Suppl 1

    Topics: Alkynes; Amino Acid Substitution; Base Sequence; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes;

2004
Viral load: new confirmation from major delavirdine studies.
    AIDS treatment news, 1996, Jan-19, Issue:no 239

    Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Delavirdine; HIV; HIV Infections;

1996
Non-nucleoside reverse transcriptase inhibitors.
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1996

    Topics: Acetamides; Acetophenones; Antiviral Agents; Delavirdine; Drug Approval; Drug Resistance, Microbial;

1996
Delavirdine (Rescriptor).
    Research initiative, treatment action : RITA, 2000, Volume: 6, Issue:1

    Topics: Delavirdine; Drug Resistance, Microbial; HIV; HIV Infections; Humans; Practice Guidelines as Topic;

2000